Colgate (NYSE: CL) COO receives 25,742-share award, 13,081 withheld for taxes

Rhea-AI Filing Summary

Colgate-Palmolive COO Panagiotis Tsourapas received 25,742 shares of Common Stock on February 23, 2026 from vesting of performance-based restricted stock units earned under the company’s incentive plan. No cash changed hands for this award.

On the same date, 13,081 shares were withheld at $97.10 per share to cover related tax liabilities. After these transactions, he directly holds 21,629 shares, plus 4,568 shares through the issuer’s 401(k) plan trustee and 62,240 shares held by a trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tsourapas Panagiotis

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO, Eur., APac, Afr Eur, Skin

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		A(1)		25,742	A	$0.0000	34,710	D
Common Stock	02/23/2026		F(2)		13,081	D	$97.1	21,629	D
Common Stock								4,568	I	By Issuer's 401(k) Plan Trustee
Common Stock								62,240(3)	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

2. Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

3. This amount includes 1,495 shares that were previously reported as directly beneficially owned.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Colgate-Palmolive (CL) COO Panagiotis Tsourapas report in this Form 4 filing?

Panagiotis Tsourapas reported vesting of 25,742 performance-based restricted stock units settled in Colgate-Palmolive Common Stock. He also reported share withholding for taxes and updated his direct and indirect share ownership totals in this insider transaction report.

How many Colgate-Palmolive (CL) shares were granted to the COO in this transaction?

The COO received 25,742 shares of Colgate-Palmolive Common Stock from vesting of previously granted performance-based restricted stock units. These units were earned under the company’s incentive compensation plan based on achievement of performance goals over a completed performance period.

Why were 13,081 Colgate-Palmolive (CL) shares disposed of in this Form 4?

The 13,081 shares were withheld to pay tax liabilities arising from the vesting of performance-based restricted stock units. This is a tax-withholding disposition at a price of $97.10 per share, rather than an open-market sale, and is tied directly to the equity award.

What is Panagiotis Tsourapas’ direct share ownership in Colgate-Palmolive (CL) after these transactions?

After the grant and tax-withholding disposition, Panagiotis Tsourapas directly owns 21,629 shares of Colgate-Palmolive Common Stock. This updated figure reflects both the vested award received and the shares withheld to satisfy tax obligations associated with that vesting event.

What indirect Colgate-Palmolive (CL) holdings does the COO report in this Form 4?

He reports 4,568 shares held indirectly through the issuer’s 401(k) plan trustee and 62,240 shares held indirectly by a trust. These positions are separate from his directly owned shares and reflect retirement-plan and trust-related ownership structures.

How were the performance-based restricted stock units (PBRSUs) for Colgate-Palmolive (CL) settled?

The PBRSUs were earned based on performance goals for a completed period and were settled solely in shares of Colgate-Palmolive Common Stock. Upon vesting, 25,742 shares were delivered, and a portion was withheld to cover the related tax liabilities.